With Authorization On Horizon, Pfizer And Merck Pills Viewed As Potential Game Changers In COVID-19 Pandemic Fight
NEW YORK (CBSNewYork) -- The Food and Drug Administration is set to authorize two different COVID-19 treatment pills as early as Wednesday.
The pills have been called potential game changers in the pandemic.
But as CBS2's Dr. Max Gomez reported Tuesday, the pills will not replace vaccines as the best weapons against the virus.
One drug comes from Pfizer and the other comes from Merck. Both have been recommended for FDA approval by independent advisory committees.
COVID VACCINE
- New York State book online here or call 1-833-NYS-4-VAX
- New York City book online here or call 877-VAX-4NYC
- Track NYC vaccinations by zip code
- Nassau County more info here
- Suffolk County more info here
- Westchester County more info here
- New Jersey book online here or call 1-855-568-0545
- Connecticut book online here
Pfizer's pill, Paxlovid, and Merck's, Molnupiravir, are seen as promising new oral treatments that can be taken at home upon onset of symptoms to help prevent COVID-19 hospitalizations and deaths.
Merck's drug, developed with Ridgeback Biotherapeutics, was shown to reduce hospitalizations and deaths by around 30% in a clinical trial of high-risk individuals early in the course of the illness. However, the FDA committee expressed some safety concerns over Molnupiravir, especially for pregnant women. Britain has already approved the Merck drug for use in people with mild to moderate COVID-19 and for those who have at least one risk factor for developing severe illness.
Meanwhile, Pfizer's Paxlovid showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients.
CORONAVIRUS PANDEMIC
- Complete COVID Vaccine Coverage
- Vaccination Sites In New York City | Call 877-VAX-4NYC
- Track NYC Vaccinations By Zip Code
- Find NYC Testing Site Near You
- Check NYC Testing Wait Times
- CDC'S COVID Vaccine FAQ
- CDC's COVID Tracking Map By County
- Resources: Help With Unemployment, Hunger, Mental Health & More
- Remote Learning Tools For Students And Parents At Home
The United States has a contract to buy as many as 5 million courses of Merck's drug, and 10 million courses of Pfizer's treatment, but most of those doses will likely not be available until early next year.
And unlike vaccines, these drugs do not prevent COVID. They may prevent serious illness and death after you've contracted the coronavirus. Plus, you have to start the drugs within five days of symptoms starting, a period when many people are still wondering if their symptoms are a cold, the flu, allergies or some other ailment. In other words, vaccines are still the first line of defense against COVID.